The North America allergy immunotherapy market is expanding steadily, driven by the increasing burden of allergic diseases, growing investments in healthcare, and widespread availability of advanced diagnostic and treatment services. Rising adoption of subcutaneous and sublingual immunotherapy, along with continuous research into next-generation allergy treatments, is supporting market growth....